The Role Of Eosinophils In Krasg12d Induced Lung Tumor Initiation And Progression

被引:0
|
作者
Li, F. [1 ]
Du, X. [1 ]
Zhang, C. [1 ]
Li, W. [1 ]
Chen, Z. [1 ]
Ying, S. [1 ]
Shen, H. [1 ]
机构
[1] Zhejiang Univ, Inst Resp Dis, Affiliated Hosp 2, Dept Resp & Crit Care Med,Sch Med, Hangzhou, Zhejiang, Peoples R China
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A2359
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Differences in gynecologic tumor development in Amhr2-Cre mice with KRASG12D or KRASG12V mutations
    Eucharist H. S. Kun
    Yvonne T. M. Tsang
    Sophia Lin
    Sophia Pan
    Tejas Medapalli
    Anais Malpica
    JoAnne S. Richards
    David M. Gershenson
    Kwong-Kwok Wong
    Scientific Reports, 10
  • [22] KrasG12D and Nkx2-1 haploinsufficiency induce mucinous adenocarcinoma of the lung
    Maeda, Yutaka
    Tsuchiya, Tomoshi
    Hao, Haiping
    Tompkins, David H.
    Xu, Yan
    Mucenski, Michael L.
    Du, Lingling
    Keiser, Angela R.
    Fukazawa, Takuya
    Naomoto, Yoshio
    Nagayasu, Takeshi
    Whitsett, Jeffrey A.
    JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (12): : 4388 - 4400
  • [23] KrasG12D, Cox-2 and Oxidative Stress
    Denicola, Gina
    Yu, Kenneth
    Blair, Ian
    Tuveson, David A.
    CANCER RESEARCH, 2006, 66 (08)
  • [24] Snail Cooperates with KrasG12D to Promote Pancreatic Fibrosis
    Shields, Mario A.
    Ebine, Kazumi
    Sahai, Vaibhav
    Kumar, Krishan
    Siddiqui, Kulsumjehan
    Hwang, Rosa F.
    Grippo, Paul J.
    Munshi, Hidayatullah G.
    MOLECULAR CANCER RESEARCH, 2013, 11 (09) : 1078 - 1087
  • [25] New exploration of KRASG12D inhibitors and the mechanisms of resistance
    Li, Ying
    Zhao, Junfeng
    Li, Yintao
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2025, 14 (01)
  • [26] Inhibition of GTPase KRASG12D: a review of patent literature
    Li, Yuhang
    Yang, Le
    Li, Xiaoran
    Zhang, Xiaojin
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2024, 34 (08) : 701 - 721
  • [27] Inflammation-Induced NFATc1-STAT3 Transcription Complex Promotes Pancreatic Cancer Initiation by KrasG12D
    Baumgart, Sandra
    Chen, Nai-Ming
    Siveke, Jens T.
    Koenig, Alexander
    Zhang, Jin-San
    Singh, Shiv K.
    Wolf, Elmar
    Bartkuhn, Marek
    Esposito, Irene
    Hessmann, Elisabeth
    Reinecke, Johanna
    Nikorowitsch, Julius
    Brunner, Marius
    Singh, Garima
    Fernandez-Zapico, Martin E.
    Smyrk, Thomas
    Bamlet, William R.
    Eilers, Martin
    Neesse, Albrecht
    Gress, Thomas M.
    Billadeau, Daniel D.
    Tuveson, David
    Urrutia, Raul
    Ellenrieder, Volker
    CANCER DISCOVERY, 2014, 4 (06) : 688 - 701
  • [28] Angiogenic Property of Mouse Pancreatic Cancer Cells From KrasG12D/p53-/- and KrasG12D/Smad4-/- Transgenic Mice, and Differential Effect of Triptolide on the Tumor Angiogenesis
    Yokoyama, Y.
    Vickers, S. M.
    Saluja, A. K.
    PANCREAS, 2009, 38 (08) : 1065 - 1065
  • [29] RMC-9805, a first-in-class, mutant-selective, covalent and oral KRASG12D(ON) inhibitor that induces apoptosis and drives tumor regression in preclinical models of KRASG12D cancers
    Jiang, Lingyan
    Menard, Marie
    Weller, Caroline
    Wang, Zhican
    Burnett, Les
    Aronchik, Ida
    Steele, Shelby
    Flagella, Mike
    Zhao, Ruiping
    Evans, James W. W.
    Chin, Shook
    Chou, Kang-Jye
    Mu, Yunming
    Longhi, Michael
    McDowell, Laura
    Knox, John E.
    Gill, Adrian
    Smith, Jacqueline A.
    Singh, Mallika
    Quintana, Elsa
    Jiang, Jingjing
    CANCER RESEARCH, 2023, 83 (07)
  • [30] RM-036, a first-in-class, orally-bioavailable, Tri-Complex covalent KRASG12D(ON) inhibitor, drives profound anti-tumor activity in KRASG12D mutant tumor models
    Knox, John E.
    Jiang, Jingjing
    Burnett, G. Leslie
    Liu, Yang
    Weller, Caroline E.
    Wang, Zhican
    McDowell, Laura
    Steele, Shelby L.
    Chin, Shook
    Chou, Kang Jye
    Wang, Fang
    Zhong, Mengqi
    Koltun, Elena S.
    Wildes, David
    Singh, Mallika
    Gill, Adrian L.
    Smith, Jacqueline A.
    CANCER RESEARCH, 2022, 82 (12)